Quimipel has been sold to CHT Group
Lincoln International, a leading global mid-market investment bank, has announced that Quimipel, a Brazilian chemical specialty supplier that provides solutions to the pulp and paper industry, has sold 100% of its quotas to CHT Group, a worldwide company focusing on special chemicals used as function generators, auxiliary materials and additives for industrial processes.
Founded in 1998, Quimipel is a leading Brazilian chemical specialty supplier to the paper, pulp and water treatment market. Its portfolio of products supplies every stage of the paper and the pulp manufacturing process. It employs over 52 people and has established long-standing relationships with blue-chip customers.
The CHT Group is a global acting supplier of specialty chemicals with a turnover of more than €400 million and around 1,800 employees worldwide. The CHT Group has been present in the Brazilian market as manufacturer of specialty chemicals, mainly for the textile industry, since 1976.
The acquisition of Quimipel offers CHT Group a significant increase in its existing paper business and is opening up South America as a new market. Additionally, Quimipel’s products and know-how will complement CHT’s worldwide product range.
Lincoln International acted as the exclusive financial advisor of Quimipel and its shareholders, performing financial models, preparing marketing materials, advising on negotiations, coordinating due diligence, reviewing documentation and coordinating all steps until closing of the transaction.
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical